{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:38:09Z","timestamp":1787600289415,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.neuro.2005.01.014","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T11:44:59Z","timestamp":1115898299000},"page":"869-881","source":"Crossref","is-referenced-by-count":33,"title":["Acute Effects of 6-Hydroxydopamine on Dopaminergic Neurons of the Rat Substantia Nigra Pars Compacta In Vitro"],"prefix":"10.1016","volume":"26","author":[{"given":"Nicola","family":"Berretta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Freestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezia","family":"Guatteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis de","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Geracitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Lipski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2005.01.014_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0926-6917(95)90018-7","article-title":"Pharmacological protection against the cytotoxicity induced by 6-hydroxydopamine and H2O2 in chromaffin cells","volume":"293","author":"Abad","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2005.01.014_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/BF00978371","article-title":"Analysis of biogenic amines in plasma of hypertensive patients and a control group","volume":"18","author":"Andrew","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2005.01.014_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0306-4522(00)00135-4","article-title":"Alpha(1)-adrenoceptor-mediated excitation of substantia nigra pars reticulata neurons","volume":"98","author":"Berretta","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2005.01.014_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3940(00)00948-4","article-title":"Extracellular toxicity of 6-hydroxydopamine on PC12 cells","volume":"283","author":"Blum","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2005.01.014_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuro.2005.01.014_bib7","first-page":"413","article-title":"Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons","volume":"174","author":"Breese","year":"1970","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuro.2005.01.014_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/exnr.1999.7259","article-title":"Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices","volume":"161","author":"Bywood","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1471-4159.2002.00802.x","article-title":"The cytotoxicity of dopamine may be an artefact of cell culture","volume":"81","author":"Clement","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.01.014_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.0953-816x.2001.01473.x","article-title":"Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease","volume":"13","author":"Costantini","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9673(00)90882-3","article-title":"Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus","volume":"99","author":"Curtius","year":"1974","journal-title":"J Chromatogr"},{"key":"10.1016\/j.neuro.2005.01.014_bib12","first-page":"195","article-title":"Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine","volume":"79","author":"Decker","year":"1993","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.neuro.2005.01.014_bib13","series-title":"Current Protocols in Neuroscience","article-title":"Loading neurons with dextran-conjugated calcium indicators in intact nervous tissue","author":"Delaney","year":"2002"},{"key":"10.1016\/j.neuro.2005.01.014_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib15","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-662-06765-9_1","article-title":"Electrophysiological pharmacology of mesencephalic dopaminergic neurons","author":"Diana","year":"2002"},{"key":"10.1016\/j.neuro.2005.01.014_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.2004.02415.x","article-title":"Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor","volume":"89","author":"Ding","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.01.014_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(98)00318-0","article-title":"Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death.","volume":"64","author":"Dodel","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuro.2005.01.014_bib18","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1060645","article-title":"Dendrodendritic inhibition through reversal of dopamine transport","volume":"293","author":"Falkenburger","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuro.2005.01.014_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2005.01.014_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0926-6917(95)90040-3","article-title":"Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine","volume":"292","author":"Glinka","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2005.01.014_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/cne.20323","article-title":"Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons","volume":"479","author":"Gonzalez-Hernandez","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2005.01.014_bib23","doi-asserted-by":"crossref","first-page":"II95","DOI":"10.1007\/PL00022909","article-title":"MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies","volume":"247","author":"Grunblatt","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib24","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1152\/jn.1998.80.5.2237","article-title":"Intracellular sodium and calcium homeostasis during hypoxia in dopamine neurons of rat substantia nigra pars compacta","volume":"80","author":"Guatteo","year":"1998","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuro.2005.01.014_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410300409","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"30","author":"Hattori","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(80)90871-9","article-title":"Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization","volume":"195","author":"Hefti","year":"1980","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2005.01.014_bib27","first-page":"297","article-title":"Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease","volume":"46","author":"Jellinger","year":"1995","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuro.2005.01.014_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/neur.1995.0016","article-title":"6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death","volume":"4","author":"Jeon","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuro.2005.01.014_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(71)90056-2","article-title":"Uptake and accumulation of 3 H-6-hydroxydopamine in adrenergic nerves","volume":"16","author":"Jonsson","year":"1971","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2005.01.014_bib30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1046\/j.1460-9568.1998.00195.x","article-title":"Hyperpolarization induces a rise in intracellular sodium concentration in dopamine cells of the substantia nigra pars compacta","volume":"10","author":"Knopfel","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1476-5381.1990.tb12998.x","article-title":"Actions of cocaine on rat dopaminergic neurones in vitro","volume":"99","author":"Lacey","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2005.01.014_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM198308043090511","article-title":"Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"309","author":"Langston","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuro.2005.01.014_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuro.2005.01.014_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0925-4439(96)00020-8","article-title":"Dopamine, 6-hydroxydopamine, iron, and dioxygen\u2013their mutual interactions and possible implication in the development of Parkinson's disease","volume":"1316","author":"Linert","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuro.2005.01.014_bib35","unstructured":"Lipski J, Freestone PS, Guatteo E, Mercuri NB, Bernardi G, Berretta N. Acute effects of 6-hydroxydopamine (6-OHDA) on dopaminergic neurons of the Substantia Nigra pars compacta (SNc) in rat brain slices. Program No. 535.18. 2003 Abstract Viewer and Itinerary Planner. Washington, DC: Society for Neuroscience."},{"key":"10.1016\/j.neuro.2005.01.014_bib36","first-page":"214","article-title":"ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction","volume":"16","author":"Liss","year":"2001","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.neuro.2005.01.014_bib37","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity","volume":"275","author":"Lotharius","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2005.01.014_bib38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.19-04-01284.1999","article-title":"Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons","volume":"19","author":"Lotharius","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0028-3908(99)00186-0","article-title":"Pharmacological identification of the K(+) currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones","volume":"39","author":"Marinelli","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2005.01.014_bib40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0024-3205(92)90479-9","article-title":"The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area","volume":"51","author":"Mercuri","year":"1992","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2005.01.014_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1460-9568.1995.tb00342.x","article-title":"Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons","volume":"7","author":"Mercuri","year":"1995","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jnr.490260405","article-title":"Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture","volume":"26","author":"Michel","year":"1990","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuro.2005.01.014_bib43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/tx990079p","article-title":"New reaction pathways of dopamine under oxidative stress conditions: nonenzymatic iron-assisted conversion to norepinephrine and the neurotoxins 6-hydroxydopamine and 6,7-dihydroxytetrahydroisoquinoline","volume":"12","author":"Napolitano","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2005.01.014_bib44","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.042497999","article-title":"Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans","volume":"99","author":"Nass","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuro.2005.01.014_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.11039","article-title":"Immunohistochemical localization of Ih channel subunits, HCN1\u20134, in the rat brain","volume":"471","author":"Notomi","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib46","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/jm970099t","article-title":"Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease","volume":"40","author":"Pezzella","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuro.2005.01.014_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0022-510X(72)90047-0","article-title":"Non-specific histopathological changes induced by the intracerebral injection of 6-hydroxy-dopamine (6-OH-DA)","volume":"16","author":"Poirier","year":"1972","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2005.01.014_bib48","first-page":"435","article-title":"A meta-analysis of Parkinson's disease and exposure to pesticides","volume":"21","author":"Priyadarshi","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2005.01.014_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/enrs.2001.4264","article-title":"Environmental risk factors and Parkinson's disease: a metaanalysis","volume":"86","author":"Priyadarshi","year":"2001","journal-title":"Environ Res"},{"key":"10.1016\/j.neuro.2005.01.014_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2005.01.014_bib51","first-page":"15","article-title":"Pathogenesis of Parkinson's disease","volume":"6","author":"Schapira","year":"1997","journal-title":"Baillieres Clin Neurol"},{"key":"10.1016\/j.neuro.2005.01.014_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneumeth.2004.02.010","article-title":"Serial induction of mutations by ethylnitrosourea in PC12 cells: a new model for a phenotypical characterization of the neurotoxic response to 6-hydroxydopamine","volume":"137","author":"Schlegel","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuro.2005.01.014_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuro.2005.01.014_bib54","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage","volume":"22","author":"Sherer","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s007020050023","article-title":"6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism","volume":"107","author":"Storch","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2005.01.014_bib56","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1046\/j.1460-9568.2003.02936.x","article-title":"Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons","volume":"18","author":"Tozzi","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuro.2005.01.014_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2005.01.014_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/1098-2396(20000901)37:3<171::AID-SYN1>3.0.CO;2-R","article-title":"Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity","volume":"37","author":"Van Kampen","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuro.2005.01.014_bib59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","article-title":"Genes, proteins, and neurotoxins involved in Parkinson's disease","volume":"73","author":"von Bohlen und Halbach","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuro.2005.01.014_bib60","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0361-9230(96)00336-X","article-title":"Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells","volume":"43","author":"Yamada","year":"1997","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuro.2005.01.014_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7","article-title":"Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion","volume":"427","author":"Zuch","year":"2000","journal-title":"J Comp Neurol"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X05000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X05000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:22:30Z","timestamp":1683094950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X05000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0161813X05000446"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2005.01.014","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}